Chorea without chorea or mental disorders as a mask of Huntington’s disease
https://doi.org/10.30629/2658-7947-2021-26-1-34-38
Abstract
Huntington’s disease (HD) is an orphan disease with an average incidence of 5.5 cases per 100 000 population. It is characterized by a high degree of penetrance, variable expressivity, manifestation in different age periods. This disorder, transmitted in an autosomal dominant way, does not have gender differences. The disease often progresses slowly but steadily over many years, eventually leading to severe disability. The clinical picture of this disease has a pathognomonic combination of neurological (extrapyramidal) and neuropsychiatric disorders. With the addition of mental disorders, especially dementia, the diagnosis of HD becomes more likely and obvious. However, if disorders in the mental sphere, including irritability, irascibility, apathy, abulia, delirium, hallucinations, impaired memory and attention, become the debut of the disease, then they largely mask clinical picture. In such cases, patients are hastily made other diagnoses: psychopathy, schizophrenia, bipolar disorder, Alzheimer’s disease, and others. You should be wary of the possible secondary nature of neuropsychiatric disorders in patients, especially young patients.
About the Authors
P. S. KrivonozhkinaRussian Federation
Volgograd
N. A. Chernaya
Russian Federation
Volgograd
V. V. Miroshnikova
Russian Federation
Volgograd
Ye. P. Makarenko
Russian Federation
Volgograd
Kh. Sh. Ansarov
Russian Federation
Volgograd
Yu. S. Vorobyova
Russian Federation
Volgograd
References
1. Xu Z., Joel Tito A., Rui Y.N., Sheng Zhang. Studying polyglutamine diseases in Drosophila. Exp. Neurol. 2015;274:25–41. https://doi.org/10.1016/j.expneurol.2015.08.002
2. Pringsheim T., Wiltshire K., Day L., Dykeman J., Steeves T., Jette N. The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov. Disord. 2012;27(9):1083–1091. https://doi.org/10.1002/mds.25075
3. Rikani A.A, Choudhry Z., Choudhry A.M., Rizvi N., Ikram H., Mobassarah N.J. et al. The mechanism of degeneration of striatal neuronal subtypes in Huntington disease. Ann. Neurosci. 2014;21(3):112–114. https://doi.org/10.5214/ans.0972.7531.210308
4. Liu, L., Huang J., Chao Han, Guo-Xin Zhang, Xiao-Yun Xu, Yan Shen et al. Induced Pluripotent Stem Cells in Huntington’s Disease: Disease Modeling and the Potential for Cell-Based Therapy. Mol. Neubiol. 2016;53:6698–6708. https://doi.org/10.1007/s12035-015-9601-8
5. Illarioshkin S.N. Huntington’s disease as a model for the study of neurodegenerative diseases. Bulletin of the National Society for the Study of Parkinson’s Disease and Movement Disorders. 2016;(1):3–11 (In Russian)
6. Bogomazova A.N., Vasina E.M., Kiselev S.L., Lagarkova M.A., Lebedeva O.S., Nekrasov E.D. et al. Genetic reprogramming of cells: a new technology for basic research and practical use. Genetics. 2015;51(4):466–478 (In Russian) https://doi.org/10.7868/S0016675815040025
7. Tabrizi S.J., Scahill R.I., Owen G., Durr A., Leavitt B.R., Roos R.A. et al. TRACK-HD Investigators. Predictors of phenotypic progression and disease onset in premanifest and earlystage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013;12:637–649. https://doi.org/10.1016/S1474-4422(13)70088-7
8. Sebastian Ag., Bram van der Gaag, Francesco A.B.C. RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA. Translational Neurodegeneration. 2017;4(2):15–17. https://doi.org/10.1186/s40035-017-0101-9
9. Klyushnikov S.A., Yudina E.N., Illarioshkin S.N., Ivanova-Smolenskaya I.A. Mental disorders in Huntington’s disease. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(2S):46–51. (In Russian)] https://doi.org/10.14412/2074-2711-2012-2508
10. Smirnov A.A., Gustov A.V., Kopishinskaya S.V., Antonova V.A. Predementia states and dementiain young people. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(2):41–43. (In Russian) https://doi.org/10.14412/2074-2711-2014-2-41-43
11. Pizova N.V., Danilova M.V. Cognitive impairments in clinical practice and analyzing the work of a memory room in Yaroslavl (an outpatient reception). Neurology, Neuropsychiatry, Psychosomatics. 2014;6(3):32–37. (In Russian) https://doi.org/10.14412/2074-2711-2014-3-32-37
12. Latimer C.S., Flanagan M.E., Cimino P.J., Jayadev S., Davis M., Hoffer Z.S. et al. Neuropathological Comparison of Adult Onset and Juvenile Huntington’s Disease with Cerebellar Atrophy: A Report of a Father and Son. J. Huntingtons Dis. 2017:6(4):337–348. https://doi.org/10.3233/JHD-170261
13. Kailash Chandra Patra, Mukund Sudhir Shirolkar. Childhood-onset (Juvenile) Huntington’s disease: A rare case report. J. Pediatr. Neurosci. 2015:10(3):276–279. https://doi.org/10.4103/1817-1745.165709
14. Choudhary A., Minocha P., Sitaraman S. A case report of juvenile Huntington disease. Journal of Pediatric and Neonatal Individualized Medicine. 2017;6(2). https://doi.org/10.7363/060217
Review
For citations:
Krivonozhkina P.S., Chernaya N.A., Miroshnikova V.V., Makarenko Ye.P., Ansarov Kh.Sh., Vorobyova Yu.S. Chorea without chorea or mental disorders as a mask of Huntington’s disease. Russian neurological journal. 2021;26(1):34-38. (In Russ.) https://doi.org/10.30629/2658-7947-2021-26-1-34-38